Stocks Swings: Las Vegas Sands Corp. (NYSE:LVS), Comcast Corporation (NASDAQ:CMCSA), LRR Energy, L.P. (NYSE:LRE), Ixia (NASDAQ:XXIA), Cerulean Pharma Inc. (NASDAQ:CERU)

On Dec 22, Las Vegas Sands Corp. (NYSE:LVS) said the company’s majority-owned subsidiary, Sands China Ltd., has received the Macao government approvals needed to complete the construction of its $2.7 billionParis-themed integrated resort. Las Vegas Sands Corp. (NYSE:LVS) belongs to Services sector. Its net profit margin is 18.20% and weekly performance is 9.79%. On last trading day company shares ended up $58.08. Las Vegas Sands Corp. (NYSE:LVS) distance from 50-day simple moving average (SMA50) is -2.90%.

The controversial Comcast Corporation (NASDAQ:CMCSA)-Time Warner Cable merger hinges on regulatory approval from the FCC and the Department of Justice, both of which are based in Washington, DC. It will come as no surprise that Comcast is trying to ingratiate itself to the DC elite by passing out cards with “priority assistance” codes to select staffers, journalists, and other influential citizens of the nation’s capital, which can help expedite service for the select few who posses the cards. Comcast Corporation (NASDAQ:CMCSA) shares moved up 1.19% in last trading session and ended the day at $57.90. CMCSA Gross Margin is 69.40% and its return on assets is 5.30%. Comcast Corporation (NASDAQ:CMCSA) quarterly performance is 5.99%.

LRR Energy (NYSE:LRE) CEO Eric D. Mullins purchased 25,000 shares of the stock in a transaction dated Wednesday, December 17th. The shares were purchased at an average cost of $8.08 per share, with a total value of $202,000.00. Following the completion of the purchase, the chief executive officer now directly owns 115,450 shares in the company, valued at approximately $932,836. On 23 December, LRR Energy, L.P. (NYSE:LRE) shares moved down -2.44% and was closed at $7.20. LRR Energy, L.P. (NYSE:LRE) year to date (YTD) performance is -52.63%.

On Dec 17, Ixia (NASDAQ:XXIA) announced enhancements to its network visibility product portfolio, which extends the capabilities of its Visibility Architecture™. With the latest releases incorporating Ixia’s Application and Threat Intelligence, comprehensive solutions come together to meet the needs of enterprises for simplified and actionable network insight. Ixia (NASDAQ:XXIA) ended the last trading day at $10.90. Company weekly volatility is calculated as 3.73% and price to cash ratio as 7.52. Ixia (NASDAQ:XXIA) showed a weekly performance of 9.50%.

On December 17, Cerulean Pharma Inc. (NASDAQ:CERU) announced that the first patient has been dosed with CRLX301 in Cerulean’s Phase 1/2a trial in patients with advanced solid tumor malignancies. CRLX301 is a nanoparticle-drug conjugate, or NDC, with a docetaxel payload, and it is the second clinical candidate from Cerulean’s Dynamic Tumor Targeting Platform. Cerulean Pharma Inc. (NASDAQ:CERU) shares moved up 5.91% in last trading session and ended the day at $6.45. CERU return on assets is -53.70%. Cerulean Pharma Inc. (NASDAQ:CERU) quarterly performance is 84.29%.